Hepatitis C
Ribapharm files patent infringement lawsuit in Germany against Hoffmann-La Roche
Published in Hepatitis Weekly, September 23rd, 2002
On August 6, the company announced that it had initiated a patent infringement action against Roche in the Netherlands and will be filing a counter-action for patent infringement against Roche in Switzerland where Roche is seeking a declaratory judgment that their marketing of ribavirin does not infringe Ribapharm's patents.
"These legal actions against Roche in Europe underscore Ribapharm's resolve to vigorously enforce and defend our patents," said Johnson Y.N. Lau, MD, president and CEO of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-09-23)
More Articles from Hepatitis Weekly
- Hepatitis B Therapy
Regimens altering lamivudine and interferon yield similar results in children - Proficiency Testing
Although hepatitis C assays are good, there is still room for improvement - Hepatitis B Therapy
New inhibitors show promise for eradicating hepatitis drug-resistant mutants - Hepatitis B Vaccine
Hip or thigh yield comparable vaccine protection in immunized infants - Kidney Failure
Hepatitis B vaccine best administered to children before end-stage liver disease - Appointments
Bill Forbes joins tapped as VP - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
